𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of diaziquone in patients with head and neck cancer

✍ Scribed by Francisco Muñiz; Enrique Vélez-García; James A. Neidhart; John F. Bender; Mark Becker

Publisher
Springer
Year
1987
Tongue
English
Weight
348 KB
Volume
19
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of mitoxantrone in head a
Phase II trial of mitoxantrone in head and neck cancer
✍ Matti S. Aapro; Davis S. Alberts 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 136 KB

Mitoxantrone (l,4-dihydroxy-5,8-bis((2-[(2-hydroxyethyl)amino]ethyl)amino)-9, 10 anthracenedione dihydrochloride, NSC 301,739) is a new aminoanthraquinone derivative with clinical activity in the treatment of advanced breast cancer (1, 2), lymphoma (3), and acute leukemia (4). We have carried out a

Phase ii trial of etoposide and doxorubi
Phase ii trial of etoposide and doxorubicin in advanced head and neck cancer
✍ Gradishar, William J. ;Vokes, Everett E. ;Kies, Merrill S. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

## Abstract In an effort to improve the response rate of patients with advanced head and neck cancer, a clinical trial combining two infrequently studied drugs was conducted. Twelve patients with squamous cell carcinoma of the head and neck were treated with 3‐day continuous infusions of etoposide

Clinical trials with fluorinated pyrimid
Clinical trials with fluorinated pyrimidines in patients with head and neck cancer
✍ Muhyi Al-Sarraf 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 851 KB

While it is estimated to be one of the most prevalent cancers in the world, cancer of the head and neck is an uncommon malignant tumor in the United States and accounts for only 5% of all malignancies [1]. Head and neck cancer is a term that encompasses heterogeneous groups of patients. The most com